These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38166743)

  • 21. Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK).
    Kaye KS; Shorr AF; Wunderink RG; Du B; Poirier GE; Rana K; Miller A; Lewis D; O'Donnell J; Chen L; Reinhart H; Srinivasan S; Isaacs R; Altarac D
    Lancet Infect Dis; 2023 Sep; 23(9):1072-1084. PubMed ID: 37182534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic epidemiology of severe community-onset Acinetobacter baumannii infection.
    Meumann EM; Anstey NM; Currie BJ; Piera KA; Kenyon JJ; Hall RM; Davis JS; Sarovich DS
    Microb Genom; 2019 Mar; 5(3):. PubMed ID: 30806611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
    Park YK; Jung SI; Park KH; Kim SH; Ko KS
    Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.
    Dijkshoorn L; Nemec A; Seifert H
    Nat Rev Microbiol; 2007 Dec; 5(12):939-51. PubMed ID: 18007677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of carbapenem resistance in Acinetobacter pittii and Acinetobacter nosocomialis isolates from Thailand.
    Singkham-In U; Chatsuwan T
    J Med Microbiol; 2018 Dec; 67(12):1667-1672. PubMed ID: 30311872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation of Antibiotic Resistance Genes in Carbapenem-Resistant
    Douraghi M; Kenyon JJ; Aris P; Asadian M; Ghourchian S; Hamidian M
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center.
    De Vos D; Pirnay JP; Bilocq F; Jennes S; Verbeken G; Rose T; Keersebilck E; Bosmans P; Pieters T; Hing M; Heuninckx W; De Pauw F; Soentjens P; Merabishvili M; Deschaght P; Vaneechoutte M; Bogaerts P; Glupczynski Y; Pot B; van der Reijden TJ; Dijkshoorn L
    PLoS One; 2016; 11(5):e0156237. PubMed ID: 27223476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of antimicrobial resistance among Acinetobacter species: a global threat.
    Clark NM; Zhanel GG; Lynch JP
    Curr Opin Crit Care; 2016 Oct; 22(5):491-9. PubMed ID: 27552304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk factors and resistance patterns of invasive
    Ge YL; Shan QW; Qiu Y; Zhou SP; Cheng YB; Wang F; Yang JW; Wan CM; Zhu Y; Xu Y; Chen MX; Lin DJ; Zhu CH; Zeng M
    Zhonghua Er Ke Za Zhi; 2022 Aug; 60(8):762-768. PubMed ID: 35922185
    [No Abstract]   [Full Text] [Related]  

  • 30. Seasonal and Temperature-Associated Increase in Community-Onset Acinetobacter baumannii Complex Colonization or Infection.
    Kim YA; Kim JJ; Won DJ; Lee K
    Ann Lab Med; 2018 May; 38(3):266-270. PubMed ID: 29401563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality.
    Li YJ; Pan CZ; Fang CQ; Zhao ZX; Chen HL; Guo PH; Zhao ZW
    BMC Infect Dis; 2017 May; 17(1):371. PubMed ID: 28558660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges in diagnosing community-acquired carbapenem-susceptible Acinetobacter baumannii enterogenic sepsis: A case report.
    Ye G; Ye L; Zhou J; Shi L; Yang L; Dong Z
    Medicine (Baltimore); 2019 Jun; 98(26):e16248. PubMed ID: 31261589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One-year molecular surveillance of carbapenem-susceptible
    Wendel AF; Malecki M; Otchwemah R; Tellez-Castillo CJ; Sakka SG; Mattner F
    Antimicrob Resist Infect Control; 2018; 7():145. PubMed ID: 30505434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic community-acquired Acinetobacter pneumonia that responded slowly to rifampicin in the anti-tuberculous regime.
    Sharma A; Shariff M; Thukral SS; Shah A
    J Infect; 2005 Oct; 51(3):e149-52. PubMed ID: 16230195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiology and clinical features of Acinetobacter baumannii infections in humans].
    Wisplinghoff H; Seifert H
    Berl Munch Tierarztl Wochenschr; 2014; 127(11-12):447-57. PubMed ID: 25872254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
    Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
    Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uncommon carbapenemase-encoding plasmids in the clinically emergent Acinetobacter pittii.
    Silva L; Mourão J; Grosso F; Peixe L
    J Antimicrob Chemother; 2018 Jan; 73(1):52-56. PubMed ID: 29069366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acinetobacter baumannii: an emerging multidrug-resistant threat.
    Gootz TD; Marra A
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States.
    Wisplinghoff H; Paulus T; Lugenheim M; Stefanik D; Higgins PG; Edmond MB; Wenzel RP; Seifert H
    J Infect; 2012 Mar; 64(3):282-90. PubMed ID: 22209744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.